Pre-loaded with half-life and reference dosage data for 100+ research peptides including BPC-157, TB-500, Semaglutide, and Retatrutide
Bibliografie: National Center for Biotechnology Information (NCBI) PMC, Glucagon-Like Peptide-1: Actions and Influence on Pancreatic Hormone Function, 2022, National Center for Biotechnology Information (NCBI) PMC, Glucagon-Like Peptide 1 (GLP-1), 2019, National Center for Biotechnology Information (NCBI) PMC, Recent Advances in Understanding the Role of Glucagon-Like Peptide 1, 2020, National Center for Biotechnology Information (NCBI) PMC, Molecular Pharmacology of Glucagon-Like Peptide 1-Based Therapies in the Management of Type Two Diabetes Mellitus and Obesity, 2025, National Center for Biotechnology Information (NCBI) PMC, GLP-1 Receptor Agonism: A Transformative Approach for Managing Type-2 Diabetes and Obesity, 2025, National Center for Biotechnology Information (NCBI), GLP-1 receptor agonists for weight loss: A systematic review and meta-analysis of randomized controlled trials,
Third, homozygous mice of IRS1 or IRS2 gene leading to peripheral IR and diabetes, and impaired insulin secretion through restrained PI3K/AKT signal transduction
PracticalCME offers a bundle discount when both courses are purchased together
